MAPT and Alzheimer disease: Therefore, considering our hypothesis of Tau loss of function when this protein is hyperphosphorylated and aggregated in pathological conditions, it is likely that dysfunctional Tau is also a consequence of impaired IGF signaling in AD and other tauopathies.